The Athlete’s Heart
Definition
Intense regular physical exercise can induce physiologic and morphologic cardiac changes known as “athlete’s heart”. These adaptations are considered a normal response to repetitive exercise training.
Physiologic Changes
- •
Increased vagal tone
- •
Morphologic changes, including left ventricular (LV) enlargement, increases in LV wall thickness, and increases in LV mass
Pathologic vs. Physiologic Hypertrophy
- •
The physiologic changes that occur in response to training can be difficult to differentiate from the pathologic processes that occur in hypertrophic cardiomyopathy (HCM) ( Table 35.1 ).
TABLE 35.1
HCM
Athlete’s Heart
Unusual pattern of LVH, may be heterogeneous
Symmetric LVH or uniform distribution of hypertrophy
Wall thickness > 16 mm
Wall thickness < 12 mm
LV cavity < 45 mm (small)
LV cavity > 55 mm (not small)
Left atrial enlargement
No left atrial enlargement
Abnormal LV filling
Normal LV filling
EKG abnormalities (see Chapter 30 )
EKG with high voltage, but no Q wave changes (see Chapter 30 )
Thickness does not decrease with deconditioning
LVH decreases with deconditioning
Family history of HCM
No family history of HCM
Positive genetic testing for HCM
Negative genetic testing for HCM
- •
Magnetic resonance imaging (MRI) can detect atypical patterns of hypertrophy and late gadolinium enhancement, which may be suggestive of HCM.
- •
If the distinction between pathologic and physiologic hypertrophy cannot be established, a period of deconditioning should be considered.
Participation Recommendations
- •
Athlete’s heart describes normal physiologic adaptations to regular intense exercise, and thus, no treatment and no limits on sports participation are required.
Sudden Cardiac Death
Epidemiology
- •
Sudden cardiac death (SCD) is the leading medical cause of death in young athletes.
- •
The actual incidence of SCD in athletes is difficult to estimate because of the lack of a mandatory national reporting system.
- •
New research suggest the incidence of SCD is around 1 in 50,000 athlete-years (AY) in college athletes and 1 in 80,000 AY in high school athletes with some higher-risk populations ( Table 35.2 ).
TABLE 35.2
Author
Year
Country
Method
Population
Incidence *
Number of Years
Age Range (Years)
Boden
2013
US
Retrospective cohort
College/high school football
1 : 112,359 college
1: 312,500 high school
Van Camp
1996
US
Retrospective cohort
College/high school athletes
1 : 300,000
10
17–24
Maron
2009
US
Retrospective cohort
Athletes
1 : 163,934
27
8–39
Steinville
2011
Israel
Retrospective cohort
Athletes
1st – 1 : 39,370
2 nd – 1 : 37,593
24
12–44
Corrado
2003
Italy
Prospective cohort study
Athletes/young people
1 : 47,600 athlete
1 : 142,900 young people
20
12–35
Holst
2010
Denmark
Retrospective cohort
Athletes/young people
1 : 82,645 athlete
1 : 26,595 general pop
7
12–35
Drezner
2005
US
Retrospective cohort
College athletes
1 : 67,000
3.3
Harmon
2011
US
Retrospective cohort
College athletes
1 : 43,000
5
18–26
Harmon
2015
US
Retrospective cohort
College athletes
1 : 53,000
10
17–26
Maron
2014
US
Retrospective cohort
College athletes
1 : 83,000 – confirmed
1 : 62,000 – presumed
10
17–26
Drezner
2009
US
Cross-sectional survey
High school athletes
1 : 23,000 SCA + SCD
1 : 46,000 SCD
Toresdahl
2014
US
Prospective observational
High school athletes
1 : 87,719 SCA + SCD
3
14–18
Maron
2012
US
Retrospective cohort
High school athletes
1 : 150,000
26
12–18
Roberts
2013
US
Retrospective cohort
High school athletes
1 : 416,666 last decade
1 : 917,000
Maron
1998
US
Retrospective cohort
High school athletes
1 : 217,000 overall
11
Marjion
2011
France
Prospective
Competitive athletes
1 : 102,00
10–35
- •
Males and African Americans are at a higher risk, with men’s basketball appearing to be at a disproportionately higher risk: 1 in 9,000 AY.
Presentation
- •
The prevalence of cardiovascular disorders in young people that can potentially lead to SCD is approximately 1 in 300.
- •
Most individuals with cardiovascular disorders will not go on to experience sudden cardiac arrest (SCA) or SCD; however, athletes may be at a higher risk because of their increased level of physical activity, which can be a trigger for arrhythmias.
- •
SCD is the presenting symptom of underlying cardiovascular pathology in 50%–90% of athletes limiting the usefulness of a history-based screen.
- •
Warning symptoms of underlying cardiovascular disease include a history of exertional chest pain, exertional syncope or presyncope, dyspnea or fatigue disproportionate to the degree of exertion, and palpitations or irregular heartbeats. Athletes with any of these symptoms require a careful workup before returning to exercise.
- •
A family history of sudden unexplained death or SCD before the age of 50 years or a history of familial cardiac disorders known to cause SCD in young athletes also warrant further diagnostic investigation before participation.
Etiology of SCD in Athletes
- •
Older studies in US athletes suggest HCM as the leading cause of SCD in athletes; however, more recent studies and studies in the US military suggest that a pathologically normal heart is the most common finding at autopsy.
- •
Studies in other countries and a recent meta-analysis also suggest HCM may be less common as a cause of SCD than previously thought ( Table 35.3 ).
TABLE 35.3
Author
Year
Country
Exertional Death vs. All Deaths
Population
Age Range (Years)
Number of Deaths
HCM
Idiopathic LVH/ Possible HCM
Coronary Artery Abnormalities
ARVC
DCM
AN-SUD
CAD
Myocarditis Related
Aortic Dissection
Other
Corrado
2003
Italy
all
Competitive athletes
12–35
55
2%
0%
13%
22%
0%
7%
20%
13%
2%
22%
De Noronha
2009
UK
all
Athletes
1–35
89
12%
25%
8%
10%
0%
19%
8%
3%
0%
4%
Maron
2009
US
all
Athletes
8–39
690
36%
8%
17%
4%
2%
–
3%
6%
3%
20%
Holst
2010
Denmark
exertional
Competitive
athletes
12–35
15
0%
7%
7%
27%
0%
27%
13%
7%
0%
13%
Suarez-Mier
2011
Spain
exertional
Recreational athletes
9–35
81
10%
9%
6%
15%
%
23%
14%
5%
0%
19%
Harmon
2014
US
all
Competitive athletes
18–26
36
3%
8%
14%
3%
8%
32%
5%
8%
8%
5% Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree